Skip to main content
The BSL-23 is the short form of Bohus’s Borderline Symptom List — the self-report severity tracker used in DBT and similar borderline-focused protocols to measure trajectory across treatment. It’s descriptive, not diagnostic. A high score doesn’t make a BPD diagnosis; a downward trend across sessions is the signal you’re after. Twenty-three items, one week look-back, free for academic and clinical use under CC-BY.

​
What it measures

Past-week severity of borderline-specific symptoms across seven implicit domains:
  • Self-perception
  • Affect regulation
  • Self-destructive impulses
  • Dysphoria
  • Loneliness and emptiness
  • Intrusions
  • Hostility
The 23 items don’t map cleanly to seven distinct subscales — Bohus designed the short form for a single severity total. Use the total score and watch the trajectory.

​
When to use it

  • Intake for borderline-focused work to establish a severity baseline.
  • Every 2-4 weeks during DBT or other borderline protocols to track trajectory.
  • Pre/post a discrete protocol phase (DBT skills modules, brief DBT, modified EMDR for CPTSD).
  • Outcome documentation at discharge.

​
How clients fill it out

Twenty-three items rated 0-4 (Not at all → Very strong) over the past week. Five to seven minutes. Reading level grade 7-8.

​
How Rivet scores it

Sum of all 23 items. Range 0-92.

​
Bands

TotalBand (mean equivalent)
0-12None to low (mean ≤0.5)
13-35Mild (mean 0.6-1.5)
36-58Moderate (mean 1.6-2.5)
59-81High (mean 2.6-3.5)
82-92Very high (mean ≥3.6)
Bands are derived from the canonical per-item mean thresholds in Kleindienst 2020’s BSL-23 validation work — the original instrument is sometimes interpreted on a 0-4 mean scale rather than a sum, and the Rivet bands translate the mean cuts back to the sum scale.

​
Self-harm / suicidality items

Items 5 (self-harm thoughts), 7 (right to live), 12 (self-punishment), and 18 (fascination with death) form a separate flagged subscale. Any score ≥ 1 on any of these surfaces a “self-harm / suicidality / death-fascination endorsed — clinical evaluation indicated” label on the result.
The self-harm subscale flag is decision-support, not a complete risk assessment. When any of items 5, 7, 12, or 18 are endorsed, do a direct risk conversation with the client and pair with the C-SSRS at intake and at any inflection point. The BSL-23 alone is not sufficient for risk stratification.

​
Clinical change

BPD severity moves slowly. A 5-10 point drop across a 12-week treatment period is in the range of effects reported in DBT outcome literature. A one-band shift (e.g. high → moderate) over a full course of treatment is the more clinically meaningful threshold for documentation.

​
Use note

BSL-23 is descriptive, not diagnostic. It tells you how severe the borderline-spectrum experience is right now — it doesn’t make a BPD diagnosis. Positive borderline screening belongs with the MSI-BPD or a structured clinical interview. Use BSL-23 once a clinical frame is established to track severity over time.

​
Citation

Bohus, M., Kleindienst, N., Limberger, M. F., Stieglitz, R. D., Domsalla, M., Chapman, A. L., Steil, R., Philipsen, A., & Wolf, M. (2009). “The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties.” Psychopathology, 42(1): 32-39. CC-BY academic/clinical use per Bohus 2009. Verbatim canonical wording.

​
When not to use it

  • You’re doing a borderline differential without an established frame. Use MSI-BPD or a structured interview first.
  • The client is under 18. BSL-23 is validated in adult samples.
  • You want a measure of emotion regulation specifically. Use the DERS-18 instead — BSL-23 is broader.

DERS-18

Emotion regulation difficulties — narrower than BSL-23 and closer to the DBT skills frame.

ITQ

Complex PTSD measure for clients whose presentation crosses BPD and CPTSD.

C-SSRS

Suicide risk screener — pair with BSL-23 when self-harm items flag.